
DNPUF
Healthcare · Drug Manufacturers - Specialty & Generic · $3.77B market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2026
EPS trend, 90 days to now
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Jul 31, 2026 | After the close | 20.59 | 0.24 | -98.8% |
| Jun 25, 2024 | After the close | — | -3.34 | — |
| Jan 31, 2024 | Before the open | — | -0.85 | — |
| Jan 30, 2023 | After the close | — | -28.24 | — |
| Oct 30, 2022 | After the close | 6.20 | -96.63 | -1658.5% |
| Jul 28, 2022 | After the close | 20.00 | 78.30 | +291.5% |
| May 12, 2022 | After the close | 6.00 | 25.30 | +321.7% |
| Jan 30, 2022 | After the close | 28.62 | 24.94 | -12.9% |
| Oct 26, 2021 | After the close | 43.05 | 79.66 | +85.0% |
| Jul 28, 2021 | After the close | 45.92 | 12.09 | -73.7% |
| May 12, 2021 | Time not confirmed | -109.40 | -35.33 | +67.7% |
| Jan 27, 2021 | After the close | 3.45 | 82.96 | +2304.6% |
| Oct 27, 2020 | After the close | 17.15 | 47.92 |
Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson's disease, type 2 diabetes, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and…
| +179.4% |
| Jul 29, 2020 | After the close | 19.66 | 45.96 | +133.8% |
| May 13, 2020 | Time not confirmed | 31.92 | -8.12 | -125.4% |
| Jan 29, 2020 | After the close | 20.58 | 34.36 | +67.0% |
| Oct 27, 2019 | After the close | 9.24 | 59.47 | +543.6% |
| Jul 28, 2019 | After the close | 28.20 | 16.87 | -40.2% |
| May 9, 2019 | After the close | 23.70 | 21.79 | -8.1% |
| Jan 30, 2019 | After the close | 22.10 | 30.45 | +37.8% |
| Oct 29, 2018 | After the close | 18.80 | 31.77 | +69.0% |
| Jul 26, 2018 | After the close | 28.05 | 38.38 | +36.8% |
| May 10, 2018 | After the close | 21.00 | 0.35 | -98.3% |
| Jan 29, 2018 | After the close | 20.85 | 39.53 | +89.6% |